S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Biden's Plan to Confiscate Your Cash? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Biden's Plan to Confiscate Your Cash? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Biden's Plan to Confiscate Your Cash? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Biden's Plan to Confiscate Your Cash? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
TSE:KPT

KP Tissue - KPT Stock Forecast, Price & News

C$10.72
+0.02 (+0.19%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
C$10.70
C$10.72
50-Day Range
C$10.19
C$10.80
52-Week Range
C$10.01
C$12.51
Volume
10,724 shs
Average Volume
14,492 shs
Market Capitalization
C$106.46 million
P/E Ratio
97.45
Dividend Yield
6.73%
Price Target
C$10.75
KPT stock logo

About KP Tissue (TSE:KPT) Stock

KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins, as well as manufactures private label tissue products. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, White Swan, and Metro brand names. The company sells its products to consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers; and through distributors to businesses involved in commercial users in the property management, healthcare, food services, manufacturing, lodging industries, and public facilities. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on KPT. Royal Bank of Canada cut their price target on shares of KP Tissue from C$11.00 to C$10.00 and set a "sector perform" rating for the company in a report on Friday, May 13th. National Bankshares lowered their price objective on shares of KP Tissue from C$11.00 to C$10.50 and set a "sector perform" rating for the company in a research report on Friday, May 13th.

KP Tissue Stock Performance

TSE:KPT opened at C$10.72 on Tuesday. The stock has a market capitalization of C$106.46 million and a P/E ratio of 97.45. The company has a 50 day moving average price of C$10.45 and a 200 day moving average price of C$10.69. KP Tissue has a fifty-two week low of C$10.01 and a fifty-two week high of C$12.51.

KP Tissue (TSE:KPT - Get Rating) last issued its quarterly earnings results on Thursday, May 12th. The company reported C$0.10 EPS for the quarter, beating the consensus estimate of C($0.07) by C$0.17. The business had revenue of C$398.74 million during the quarter, compared to analysts' expectations of C$408.45 million. Research analysts forecast that KP Tissue will post 0.36 earnings per share for the current fiscal year.

KP Tissue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 15th. Shareholders of record on Thursday, June 30th were given a $0.18 dividend. The ex-dividend date was Wednesday, June 29th. This represents a $0.72 annualized dividend and a yield of 6.72%. KP Tissue's dividend payout ratio is presently 654.55%.

Receive KPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter.

KPT Stock News Headlines

Kp Tissue Inc stock advanced on Tuesday.
Kp Tissue Inc stock advanced on Friday.
Kp Tissue Inc stock boosted on Friday.
Kp Tissue Inc stock eased on Tuesday.
Instrument Name Kp Tissue Inc Instrument Symbol (KPT-T)
New Sherbrooke Plant Doubles its Tissue Paper Capacity
KP Tissue Releases Third Quarter 2021 Financial Results
2 of the Best TSX Dividend Stocks With Yields Near 7%
3 High-Yield Canadian Stocks at Rock-Bottom Prices
KP Tissue Releases First Quarter 2021 Financial Results
Stocks in play: KP Tissue Inc.
This Toilet Paper Stock Could Make You a Billionaire
See More Headlines
Receive KPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter.

KPT Company Calendar

Last Earnings
5/12/2022
Ex-Dividend for 7/15 Dividend
6/29/2022
Dividend Payable
7/15/2022
Today
8/08/2022
Next Earnings (Estimated)
8/11/2022

Industry, Sector and Symbol

Industry
Personal Products
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$10.75
High Stock Price Forecast
C$11.50
Low Stock Price Forecast
C$10.00
Forecasted Upside/Downside
+0.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
C$8.64 per share

Miscellaneous

Free Float
N/A
Market Cap
C$106.46 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Dino J. Bianco (Age 60)
    Chief Exec. Officer
    Comp: $923.12k
  • Mr. Mark Holbrook
    Chief Financial Officer
  • Mr. Michel Manseau
    Sr. VP & GM of Consumer Bus. Canada - Kruger Products LP
  • Mr. Gordon Goss
    Sr. VP and GM of Consumer Bus. USA & Mexico - Kruger Products LP
  • Mr. Marc James Fitzgerald
    Corp. VP of Technology & Product Devel. - Kruger Products LP
  • Mike Baldesarra CPA
    CA, Director of Investor Relations
  • Mr. François Paroyan
    SVP of Gen. Counsel & Corp. Affairs and Corp. Sec.
  • Mr. Rob Latter
    Sr. VP & GM of Away from Home Bus. - Kruger Products LP
  • Ms. Nancy Marcus
    Chief Marketing Officer of Kruger Products LP
  • Ms. Susan Irving
    Chief Marketing Officer of KPLP













KPT Stock - Frequently Asked Questions

Should I buy or sell KP Tissue stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KPT, but not buy additional shares or sell existing shares.
View KPT analyst ratings
or view top-rated stocks.

What is KP Tissue's stock price forecast for 2022?

4 analysts have issued 1-year price targets for KP Tissue's stock. Their KPT share price forecasts range from C$10.00 to C$11.50. On average, they predict the company's stock price to reach C$10.75 in the next twelve months. This suggests a possible upside of 0.3% from the stock's current price.
View analysts price targets for KPT
or view top-rated stocks among Wall Street analysts.

How has KP Tissue's stock price performed in 2022?

KP Tissue's stock was trading at C$10.41 at the beginning of the year. Since then, KPT shares have increased by 3.0% and is now trading at C$10.72.
View the best growth stocks for 2022 here
.

When is KP Tissue's next earnings date?

KP Tissue is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our KPT earnings forecast
.

How were KP Tissue's earnings last quarter?

KP Tissue Inc. (TSE:KPT) released its quarterly earnings results on Thursday, May, 12th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.17. The firm had revenue of $398.74 million for the quarter, compared to the consensus estimate of $408.45 million.

How often does KP Tissue pay dividends? What is the dividend yield for KP Tissue?

KP Tissue announced a quarterly dividend on Thursday, May 12th. Stockholders of record on Thursday, June 30th will be given a dividend of 0.18 per share on Friday, July 15th. This represents a $0.72 annualized dividend and a dividend yield of 6.72%. The ex-dividend date is Wednesday, June 29th.
Read our dividend analysis for KPT
.

Is KP Tissue a good dividend stock?

KP Tissue (TSE:KPT) pays an annual dividend of C$0.72 per share and currently has a dividend yield of 6.73%. KPT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 654.55%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for KPT.

What other stocks do shareholders of KP Tissue own?

What is KP Tissue's stock symbol?

KP Tissue trades on the Toronto Stock Exchange (TSX) under the ticker symbol "KPT."

How do I buy shares of KP Tissue?

Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is KP Tissue's stock price today?

One share of KPT stock can currently be purchased for approximately C$10.72.

How much money does KP Tissue make?

KP Tissue (TSE:KPT) has a market capitalization of C$106.46 million.

How can I contact KP Tissue?

KP Tissue's mailing address is 1900 Minnesota Crt Suite 200, MISSISSAUGA, ON L5N 5R5, Canada. The official website for the company is kptissueinc.com. The company can be reached via phone at +1-905-8126900.

This page (TSE:KPT) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.